APLT logo

Applied Therapeutics (APLT) Company Overview

Profile

Full Name:

Applied Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 14, 2019

Indexes:

Not included

Website:

http://www.appliedtherapeutics.com

Description:

Applied Therapeutics, Inc. is a biopharmaceutical company that develops products for the treatment of cardiovascular diseases, galactosemia, and diabetic complications. Applied Therapeutics, Inc. was founded in 2016 with headquarters in New York, New York. The portfolio of Applied Therapeutics includes three main products: AT-007 - being developed for the treatment of galactosemia, a rare and destructive pediatric metabolic disorder. AT-001 - a product with broad systemic impact and peripheral nerve permeability, being developed for the treatment of diabetic cardiomyopathy and fatal heart fibrosis. AT-003 - intended for the treatment of diabetic retinopathy or DR. DR is an ophthalmic disease that occurs in patients with diabetes, its treatment is limited to the use of expensive biologics requiring intravitreal injection.

Key Details

Price

$0.51

Market Cap

$59.50 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$9.99 M

Annual EPS

-$1.42(+34.86% YoY)

PE Ratio

-

Annual ROE

698.49%

Annual Debt To Equity

-0.02

Beta

1.03

Events Calendar

Earnings

Next earnings date:

Mar 6, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 23, 24 William Blair
Market Perform
Dec 20, 24 RBC Capital
Sector Perform
Dec 2, 24 UBS
Neutral
Nov 29, 24 RBC Capital
Sector Perform
Nov 29, 24 Citigroup
Buy
Nov 29, 24 Baird
Outperform
Nov 27, 24 Citigroup
Buy
Sep 19, 24 Leerink Partners
Outperform
Sep 19, 24 Citigroup
Buy
Aug 27, 24 Citigroup
Buy

Screeners with APLT included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Most recommended stocks
Earnings tomorrow
Stocks below analysts price target
Healthcare sector
All stocks
Stocks with high beta

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.51
APLT price is $0.51

Price All-time High

$55.47
APLT price is currently -99.08% below its historical high of $55.47

Price Analysts Target

$5.00
APLT price is currently -89.77% lower than the consensus analysts' forecast

Price Most Recent Change

+4.5%
APLT price was up +4.5% on Mar 6, 2025

Price YTD Change

-41.85%
APLT price is down -41.85% since January 1st

Price 3-Year Change

-69.19%
APLT price is down -69.19% over the past 3 years

Market cap

Market Cap

$59.50 M
APLT market capitalization is $59.50 million

Market Cap 3-Year Change

+36.74%
APLT market capitalization is up +36.74% over the past 3 years

Market Cap All-time High

$1.20 B
APLT market capitalization is currently -95.05% below its historical high of $1.20 billion

Market Cap Sector Rank

38.6%
APLT market capitalization is higher than 38.6% of companies in Healthcare sector

Technical

Beta

1.03
APLT beta is 1.03

200-day SMA

$4.70
APLT price is currently -89.11% below its 200-day simple moving average

14-day RSI

34.42
APLT 14-day relative strength index is 34.42

30-day Relative Volume

0.51
APLT 30-day relative volume is 0.51

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$9.99 M
APLT annual revenue is $9.99 million

Annual Revenue Analysts Estimate

$553.00 K
APLT annual revenue is currently +1707.05% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-
APLT annual revenue 1-year change is unknown

Annual Revenue Sector Rank

31.72%
APLT annual revenue is higher than 31.72% of companies in Healthcare sector

Profit

Annual Gross Profit

-
APLT annual gross profit value is unknown

Annual Gross Margin

-
APLT annual gross profit margin value is unknown

Annual Operating Profit

-$64.53 M
APLT annual operating income is -$64.53 million

Annual Operating Margin

-645.80%
APLT annual operating profit margin is -645.80%

Annual Net Income

-$119.76 M
APLT annual net profit is -$119.76 million

Annual Net Margin

-1198.47%
APLT annual net profit margin is -1198.47%

EPS

Annual EPS

-$1.42
APLT annual earnings per share is -$1.42

Annual EPS Analysts Estimate

-$1.33
APLT annual earnings per share is currently +6.86% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+34.86%
APLT annual earnings per share is up +34.86% year-on-year

Annual EPS Sector Rank

50.6%
APLT annual earnings per share is higher than 50.6% of companies in Healthcare sector

ROA & ROE

Annual ROA

-218.41%
APLT annual return on assets is -218.41%

Annual ROE

698.49%
APLT annual return on equity is 698.49%

EBIT & EBITDA

Annual EBIT

-$64.53 M
APLT annual earnings before interest & taxes is -$64.53 million

Annual EBITDA

-$64.18 M
APLT annual EBITDA is -$64.18 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
APLT price to earnings ratio value is unknown

PE Ratio Sector Rank

-
APLT price to earnings ratio is unknown

PB Ratio

PB Ratio

10.10
APLT price to book ratio is 10.10

PB Ratio Sector Rank

91.75%
APLT price to book ratio is higher than 91.75% of companies in Healthcare sector

PS Ratio

PS Ratio

-282.01
APLT price to sales ratio is -282.01

PS Ratio Sector Rank

0%
APLT price to sales ratio is higher than 0% of companies in Healthcare sector

Enterprise value

Enterprise Value

-$37.39 M
APLT enterprise value is -$37.39 million

Enterprise Value Sector Rank

2.18%
APLT enterprise value is higher than 2.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.41
APLT EV/EBITDA is 0.41

EV/EBITDA Sector Rank

72.68%
APLT EV/EBITDA is higher than 72.68% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.76
APLT annual current ratio is 0.76

Annual Quick Ratio

-
APLT annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.02
APLT annual debt to equity ratio is -0.02

Annual Interest Coverage Ratio

-
APLT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
APLT piotroski f-score value is unknown

Altman Z-Score

-15.54
APLT altman z-score is -15.54

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$54.83 M
APLT annual total assets is $54.83 million

Annual Non Current Assets

$447.00 K
APLT annual long term assets is $447.00 thousand

Annual Current Assets

$54.39 M
APLT annual total current assets is $54.39 million

Annual Cash & Cash Equivalents

$49.90 M
APLT annual cash & cash equivalents is $49.90 million

Equity

Annual Book Value

-$17.15 M
APLT annual book value is -$17.15 million

Annual Working Capital

-$16.80 M
APLT annual working capital is -$16.80 million

Liabilities

Annual Total Liabilities

$71.98 M
APLT annual total liabilities is $71.98 million

Annual Total Long Term Liabilities

$797.00 K
APLT annual total long term liabilities is $797.00 thousand

Annual Current Liabilities

$71.18 M
APLT annual total current liabilities is $71.18 million

Annual Accounts Payable

$1.74 M
APLT annual accounts payable is $1.74 million

Debt

Annual Total Debt

$777.00 K
APLT annual total debt is $777.00 thousand

Annual Total Debt 1-Year Change

-48.65%
APLT annual total debt is down -48.65% year-on-year

Annual Long Term Debt

$38.00 K
APLT annual long term debt is $38.00 thousand

Annual Short Term Debt

$739.00 K
APLT annual short term debt is $739.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$74.53 M
APLT annual total expenses is $74.53 million

Annual Operating Expenses

$74.53 M
APLT annual total operating expenses is $74.53 million

Annual Cost Of Goods Sold

-
APLT annual cost of goods sold value is unknown

Annual SGA

$20.62 M
APLT annual SGA is $20.62 million

Annual D&A

$354.00 K
APLT annual depreciation & amortization is $354.00 thousand

Annual Interest Expense

-
APLT annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$55.17 M
APLT annual cash flow from operations is -$55.17 million

Annual CFO 1-Year Change

+29.35%
APLT annual cash flow from operations is up +29.35% year-on-year

Annual CFI

$13.87 M
APLT annual cash flow from investing activities is $13.87 million

Annual CFI 1-Year Change

+5.33%
APLT annual cash flow from investing activities is up +5.33% year-on-year

Annual CFF

$74.54 M
APLT annual cash flow from financing activities is $74.54 million

Annual CFF 1-Year Change

+169.18%
APLT annual cash flow from financing activities is up +169.18% year-on-year

Free CashFlow

Annual FCF

-$55.17 M
APLT annual free cash flow is -$55.17 million

Annual FCF 1-Year Change

+29.35%
APLT annual free cash flow is up +29.35% year-on-year

CAPEX

Annual CAPEX

-
APLT annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
APLT annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

IOBT logo
IO Biotech (IOBT)
UNCY logo
Unicycive Therapeutics (UNCY)
SCLX logo
Scilex Holding (SCLX)
STTK logo
Shattuck Labs (STTK)
XGN logo
Exagen (XGN)
ICAD logo
iCAD (ICAD)
NEUE logo
NeueHealth (NEUE)
BEAT logo
HeartBeam (BEAT)
PRE logo
Prenetics Global Limited (PRE)

FAQ

  • What is the ticker symbol for Applied Therapeutics?
  • Does Applied Therapeutics pay dividends?
  • What sector is Applied Therapeutics in?
  • What industry is Applied Therapeutics in?
  • What country is Applied Therapeutics based in?
  • When did Applied Therapeutics go public?
  • Is Applied Therapeutics in the S&P 500?
  • Is Applied Therapeutics in the NASDAQ 100?
  • Is Applied Therapeutics in the Dow Jones?
  • When was Applied Therapeutics's last earnings report?
  • When does Applied Therapeutics report earnings?
  • Should I buy Applied Therapeutics stock now?

What is the ticker symbol for Applied Therapeutics?

The ticker symbol for Applied Therapeutics is NASDAQ:APLT

Does Applied Therapeutics pay dividends?

No, Applied Therapeutics does not pay dividends

What sector is Applied Therapeutics in?

Applied Therapeutics is in the Healthcare sector

What industry is Applied Therapeutics in?

Applied Therapeutics is in the Biotechnology industry

What country is Applied Therapeutics based in?

Applied Therapeutics is headquartered in United States

When did Applied Therapeutics go public?

Applied Therapeutics's initial public offering (IPO) was on May 14, 2019

Is Applied Therapeutics in the S&P 500?

No, Applied Therapeutics is not included in the S&P 500 index

Is Applied Therapeutics in the NASDAQ 100?

No, Applied Therapeutics is not included in the NASDAQ 100 index

Is Applied Therapeutics in the Dow Jones?

No, Applied Therapeutics is not included in the Dow Jones index

When was Applied Therapeutics's last earnings report?

Applied Therapeutics's most recent earnings report was on Nov 7, 2024

When does Applied Therapeutics report earnings?

The next expected earnings date for Applied Therapeutics is Mar 6, 2025

Should I buy Applied Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions